Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia
Kersting, S.; Levin, M-D.; Chamuleau, M.; Daenen, S.M.G.J.; Dompeling, E.C.; Doorduijn, J.K.; van Gelder, M.; Hoogendoorn, M.; Kerst, J.M.; Nijland, M.; Nijziel, M.R.; Posthuma, E.F.M.; Raymakers, R.A.P.; Schaafsma, M.R.; Silbermann, M.H.; van der Straaten, H.M.; Veelken, J.H.; Vos, J.M.I.; Wittebol, S.; van Oers, M.H.J.; Kater, A.P.
Netherlands Journal of Medicine 74(2): 68-74
2016
ISSN/ISBN: 0300-2977 PMID: 26951351 Document Number: 688001
In recent years, considerable progress has been made in the treatment of patients with chronic lymphocytic leukaemia (CLL). Therefore, the CLL working group of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) framework revised the Dutch guidelines based on new studies and expert opinion of members of the working group.